When peritumorally injected into the brain, the obtained exosomes CpG-STAT3-ASO-Cy3 displayed more efficient targeted delivery toward the tumor-associated myeloid cells, such as microglia, macrophages, and MDSCs, compared with the injection of oligonucleotide alone. The gene discussed is STAT3; the disease is neoplasm.